Revvity to acquire Human Cell Design
Engineered immune cells trial to fight colorectal cancer approved
Elix and Axcelead DDP to collaborate on targeted protein degrader discovery
Lotus Neuro launches to deliver therapies across blood-brain barrier
PhoreMost demonstrates new approach to molecular glue drug discovery
New molecular degraders offer hope in aggressive breast cancer fight
Cells repair toxic DNA damage linked to cancer and premature ageing
Elix provides AI drug discovery platform to Eisai
Johnson & Johnson receives Priority Review for high-risk non-muscle invasive bladder cancer treatment
Bakar Labs to build new R&D facility for biotechs
Sanofi to acquire vaccine biotech Vicebio for $1.6bn
Elix and LINC combine on new drug discovery platform